20 Years of FDA Innovation

FDA deputy commissioner for policy, planning, legislation, and analysis Anna Abram reviewed 20 years of FDA history in a 10/24 speech to the JAX Healthcare Forum “to illustrate how innovation is truly part of FDA’s DNA. FDA plays an important role in the biomedical ecosystem, working with scientists, other government agencies, nonprofits, industry, healthcare providers, and payers to help bring innovative products to patients and consumers.”

Embedded in the agency’s mission statement, Abram said, is the pledge to promote as well as protect the public health and that to do so requires it to do what it can to help advance medical products in a timely manner to the people who need them.

Her presentation covered regulatory demands of specific evolving technologies, what the agency is doing to help with medical product translation, FDA’s role in healthcare costs, collaborating with payers, and the patient voice in product development.